Thursday, September 11, 2014 | 8:00 AM - 2:00 PM
Featuring Award Winners: Emmanuelle Charpentier (Helmholtz Centre for Infection Research) and Jennifer Doudna (Howard Hughes Medical Institute/University of California, Berkeley)
Honor Drs. Emmanuelle Charpentier and Jennifer Doudna, recipients of the 2014 Dr. Paul Janssen Award for Biomedical Research.
Monday, September 15, 2014 | 12:00 PM - 4:00 PM
Keynote Speakers: Jim Paulson (The Scripps Research Institute), K. Barry Sharpless (The Scripps Research Institute)
Speakers: Yimon Aye (Cornell University), David A. Spiegel (Yale University), Mingxuan Wu (Princeton University), Peng Wu (Albert Einstein College of Medicine)
Click chemistry offers a reliable method for discovering chemical connectivity, with great potential in drug discovery and biomedical research. This symposium explores recent developments that offer new technologies for disease diagnosis and therapy.
Friday, September 26, 2014 | 8:30 AM - 5:15 PM
Speakers: Shari Barkin (Vanderbilt University Medical Center), Mina Desai (University of California Los Angeles), Maria Gloria Dominguez-Bellow (New York University School of Medicine), Lawrence B. Finer (Guttmacher Institute), Stephen A. Krawetz (Wayne State University School of Medicine), Nancy F. Krebs (University of Colorado Denver), Julie A. Mennella (Monell Chemical Senses Center), Nico S. Rizzo (Loma Linda University), Linda M. Szymanski (Johns Hopkins Medicine), Mark Lawrence Wahlqvist (Zhejiang University), Jane Wardle (University College London), Rob A. Waterland (Baylor College of Medicine), Christiane Wrann (Dana-Farber Cancer Institute)
This conference will present how maternal nutrition, the microbiome, metabolic disorders, and fetal development affect obesity rates.
Thursday, October 9, 2014 | 8:00 AM - 4:00 PM
Keynote Speakers: Neesha Dhani (Princess Margaret Hospital, Toronto), Steven D. Leach (Memorial Sloan Kettering Cancer Center)
Speakers: Gregory Beatty (University of Pennsylvania Perelman School of Medicine), Mikala Egeblad (Cold Spring Harbor Laboratory), Douglas T. Fearon (Cold Spring Harbor Laboratory), Costas A. Lyssiotis (Weill Cornell Medical College ), George Miller (NYU Langone Medical Center), Michael Ports (Gilead Sciences)
Pancreatic cancer patients currently have limited therapeutic options. This symposium explores breakthroughs in the pathogenesis and progression of pancreatic cancer, and efforts to exploit key vulnerabilities for novel therapeutic interventions.
Friday, October 10, 2014 | 8:00 AM - 3:15 PM
Keynote Speaker: The Honorable Patrick J. Kennedy
Former United States Representative, Rhode Island; One Mind for Research; Kennedy Forum
This conference will explore the translation of recent breakthroughs in neuroscience into therapies for the more than twenty-five percent of Americans suffering from mental illnesses such as schizophrenia, depression, fear and anxiety disorders, autism, and other psychiatric disorders. A keynote lecture by The Honorable Patrick J Kennedy will address strategies to simultaneously abolish the stigma surrounding mental illness in order to fully realize the potential of these new treatments to improve mental health.
Thursday, June 26, 2014 | 7:45 AM - 6:00 PM
Keynote Speaker: Robin Franklin (Wellcome Trust – MRC Cambridge Stem Cell Institute, University of Cambridge)
This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.
June 19 - 20, 2014
Keynote Speaker: Harold F. Dvorak (Beth Israel Deaconess Medical Center)
This conference will examine issues in anti-angiogenic cancer therapy such as: (i) inherent / acquired resistance, (ii) immunomodulation (iii) enhanced invasiveness, and (iv) lack of validated predictive and prognostic biomarkers. Presentations, including a keynote lecture by Harold F. Dvorak, MD, will explore VEGF-dependent and alternative mechanisms of angiogenesis. Expert "point–counter point" debates will aim to resolve controversies regarding vascular normalization, treatment-induced metastasis, and the validity of hypertension as a physiological biomarker.
Monday, June 9, 2014 | 10:00 AM - 3:15 PM
Featured Speakers: John J. O'Shea (National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH), James P. Allison (The University of Texas MD Anderson Cancer Center), Louis M. Staudt (National Cancer Institute, National Institutes of Health), Charles A. Dinarello (University of Colorado at Denver)
This symposium will honor Dr. John O'Shea, the recipient of the 2014 Ross Prize in Molecular Medicine, in recognition of his discoveries in immunology and cytokine biology.
Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM
Keynote Speaker: Michael Marletta (The Scripps Research Institute)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents three meeting reports: (1) Production and supply of high-quality food protein for human consumption: sustainability, challenges, and innovations; (2) Clinical and economic outcomes of nutrition interventions across the continuum of care; and (3) Antibody–drug conjugates: an emerging modality for the treatment of cancer.
Speakers: James P. Allison (University of Texas MD Anderson Cancer Center), Charles A. Dinarello (University of Colorado–Denver), and John J. O'Shea (National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH)
This eBriefing features John J. O'Shea, recipient of the 2014 Ross Prize in Molecular Medicine for his discoveries in immunology and cytokine biology.
Edited by Charles W. Fox
(University of Kentucky) and Timothy A. Mousseau
(University of South Carolina)
This Annals volume features five in-depth review articles of diverse issues in evolutionary biology.
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation), Kevin J. Lee (Lawrence Ellison Foundation), and Jennifer Henry (The New York Academy of Sciences)
This eBriefing explores advances in the science of aging and in drug discovery for Alzheimer's and other neurodegenerative diseases.
Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.
September 10, 2010
Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.
Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.